Release Date: 04/05/23 08:15 Summary: Change in substantial holding from RMS Price Sensitive: No Download Document 97.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%